Close Menu

NEW YORK (GenomeWeb) – Quanterix today said that it has priced a public offering of 2,376,238 shares of its common stock at an offering price of $25.25 per share. 

The Billerica, Massachusetts-based firm expects to bring in around $60 million in gross proceeds, before underwriting discounts and expenses. The company also has granted the underwriters a 30-day option to purchase up to an additional 356,435 shares of common stock at the same offering price.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.